Anteris Technologies Global (NASDAQ:AVR) Major Shareholder Purchases $573,487.92 in Stock

Anteris Technologies Global Corp. (NASDAQ:AVR) major shareholder L1 Capital Pty Ltd purchased 74,286 shares of the stock in a transaction dated Wednesday, September 30th. The shares were bought at an average price of $7.72 per share, for a total transaction of $573,487.92. Following the completion of the acquisition, the insider owned 4,877,827 shares in the company, valued at $37,656,824.44. This represents a 1.55% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website. Major shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

L1 Capital Pty Ltd also recently made the following trade(s):

• On Thursday, October 1st, L1 Capital Pty Ltd acquired 322,940 shares of Anteris Technologies Global stock. The shares were purchased at an average price of $7.60 per share, with a total value of $2,454,344.00.
• On Friday, August 28th, L1 Capital Pty Ltd sold 7,800 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.83, for a total value of $68,874.00.
• On Tuesday, August 11th, L1 Capital Pty Ltd sold 375,815 shares of Anteris Technologies Global stock. The shares were sold at an average price of $9.30, for a total value of $3,495,079.50.
• On Monday, August 10th, L1 Capital Pty Ltd sold 251,844 shares of Anteris Technologies Global stock. The shares were sold at an average price of $9.10, for a total value of $2,291,780.40.
• On Thursday, August 6th, L1 Capital Pty Ltd sold 174,721 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.10, for a total value of $1,415,240.10.
• On Tuesday, August 4th, L1 Capital Pty Ltd sold 480,608 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.30, for a total value of $3,989,046.40.
• On Wednesday, August 5th, L1 Capital Pty Ltd sold 14,581 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.23, for a total value of $120,001.63.
• On Monday, August 3rd, L1 Capital Pty Ltd sold 475,693 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.10, for a total value of $3,853,113.30.
• On Friday, July 31st, L1 Capital Pty Ltd sold 48,711 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.15, for a total value of $396,994.65.
• On Wednesday, July 29th, L1 Capital Pty Ltd sold 155,505 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.04, for a total value of $1,250,260.20.

Anteris Technologies Global Stock Performance

Shares of AVR opened at $7.71 on Friday. The firm has a market cap of $751.40 million, a PE ratio of -3.95 and a beta of 1.87. The firm’s 50 day moving average price is $8.50 and its 200 day moving average price is $7.98. Anteris Technologies Global Corp. has a twelve month low of $3.30 and a twelve month high of $11.06.

Anteris Technologies Global (NASDAQ:AVR) last posted its earnings results on Tuesday, August 11th. The company reported ($0.30) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.09). Anteris Technologies Global had a negative net margin of 4,619.27% and a negative return on equity of 77.69%. The business had revenue of $1.01 million during the quarter, compared to analyst estimates of $1.50 million. During the same quarter last year, the firm earned ($0.58) earnings per share. On average, sell-side analysts anticipate that Anteris Technologies Global Corp. will post -1.21 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on AVR. Weiss Ratings reiterated a “sell (d-)” rating on shares of Anteris Technologies Global in a report on Wednesday, August 26th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $15.00 price target on shares of Anteris Technologies Global in a research report on Friday, August 14th. Four research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $16.00.

Institutional Investors Weigh In On Anteris Technologies Global

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Nantahala Capital Management LLC bought a new position in shares of Anteris Technologies Global in the second quarter worth about $33,325,850. One68 Global Capital LLC bought a new stake in Anteris Technologies Global during the 2nd quarter valued at approximately $128,000. Bank of America Corp DE bought a new stake in Anteris Technologies Global during the 2nd quarter valued at approximately $1,907,000. AWM Investment Company Inc. acquired a new stake in Anteris Technologies Global in the 2nd quarter valued at approximately $1,133,000. Finally, ADAR1 Capital Management LLC acquired a new stake in Anteris Technologies Global in the 2nd quarter valued at approximately $30,979,000.

About Anteris Technologies Global

Anteris Technologies Global is a clinical-stage structural heart company developing technologies intended to treat aortic valve disease. The company’s lead product is the DurAVR transcatheter heart valve, which is designed to replicate the performance characteristics of a healthy human aortic valve and restore more natural blood flow.

Anteris uses its proprietary ADAPT tissue-engineering technology to create heart-valve materials designed for durability and biocompatibility. The company is focused primarily on transcatheter aortic valve replacement and related structural-heart applications, with its products progressing through clinical development and regulatory evaluation rather than broad commercial distribution.

The company has Australian origins and maintains operations and clinical-development activities in both Australia and the United States.